### Background Research on the Kind-Philipp-Preis and Pediatric Cancer Research
#### Overview of Pediatric Cancer
Pediatric cancer is a term that encompasses a variety of cancers affecting children and adolescents. While childhood cancers are relatively rare compared to adult cancers, they represent a significant health concern. The most common types of pediatric cancer include leukemia, brain tumors, neuroblastoma, Wilms tumor, and lymphoma.
#### Advances in Diagnosis and Treatment
In recent years, there has been substantial progress in understanding the genetics of pediatric cancers which has led to developments in targeted therapies. Modern diagnostic methods involving advanced imaging technologies and genetic testing allow for earlier diagnosis which can improve treatment outcomes significantly.
Innovative treatments such as immunotherapies (which help the immune system recognize and fight cancer), precision medicines tailored to genetic abnormalities present in specific tumors, and less invasive surgical techniques have contributed greatly to improving survival rates among children with cancer.
#### Hopp-Kindertumorzentrum Heidelberg (KiTZ)
The Hopp-Kindertumorzentrum Heidelberg is dedicated exclusively to conducting research focused on pediatric tumors. It brings together experts from various fields including oncology, epidemiology, molecular biology, genetics, nursing care as well as psychosocial support professionals—a multidisciplinary approach that aims at ensuring comprehensive care for young patients.
#### Kind-Philipp-Stiftung
The Kind-Philipp-Stiftung was established with the purpose of funding research projects aimed at discovering new treatments or improving existing therapies for childhood cancers. Named after Philipp Albrecht—a child who bravely fought against cancer—the foundation emphasizes investment into scientific advancements that strive towards offering better therapeutic options for children affected by these diseases.
—
### FAQ Section
**Q1: What is the Kind-Philipp-Preis?**
A1: The Kind-Philipp-Preis is an award recognizing outstanding achievements in research focused on pediatric oncology (the study of cancer in children). It honors researchers who contribute significantly towards modern diagnostic methods or treatment procedures aimed at helping young patients with cancer.
**Q2: Who received the KInd-Philipp-Prize 2023?**
A2: In 2023, Franziska Blaeschke, Dominik Sturm alongside David Jones—from institutions including Hopp-Kindertumorzentrum Heidelberg (KiTZ), Deutsches Krebsforschungszentrum (DKFZ), and Universitätsklinikum Heidelberg (UKHD)—were awarded this prize for their exceptional work on modern diagnosis protocols plus treatment methodologies specifically designed for children suffering from malignancies.
**Q3: How much monetary value does this award carry?**
A3: The award comes with a recognition prize amounting to 10.000 Euros aimed at further supporting ongoing research endeavors undertaken by winning recipients or contributing towards new projects down the line.
**Q4: When was this award ceremony held?**
A4: The awarding took place on November 22nd during an assembly organized by Gesellschaft für Pädiatrische Hämatologie und Onkologie held in Frankfurt—an event gathering healthcare professionals dedicated toward enhancing standards surrounding childhood hematology-oncology expertise ranging from clinicians through educators all supported collectively under unified goals fitting progressive patient management tactics governing cases throughout Germany broadly speaking!
**Q5 How does funding like that from Kind-Phiip Stiftung aid medical breakthroughs?**
A5 Financial contributions made via foundations such as „Kind Philipp Stiftung“ enable researchers access more resources required – inclusive cutting-edge tools vital when investigating approaches towards tackling complexities associated pediatric tumours while also fostering collaboration among scientists across disciplines generating collective insights critical advancing knowledge frontiers relevant combating challenging diseases impacting our youth directly!
Originamitteilung:
Für ihre herausragende Forschung an modernen Diagnose- und Behandlungsverfahren für krebskranke Kinder und Jugendliche werden Franziska Blaeschke, Dominik Sturm und David Jones vom Hopp-Kindertumorzentrum Heidelberg (KiTZ), dem Deutschen Krebsforschungszentrum (DKFZ) und dem Universitätsklinikum Heidelberg (UKHD) mit dem Kind-Philipp-Preis 2023 geehrt. Der Preis ist mit insgesamt 10.000 Euro dotiert und wurde am 22. November bei der Tagung der Gesellschaft für Pädiatrische Hämatologie und Onkologie in Frankfurt von der Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung verliehen.